29 February is Rare Disease Day

29 February is Rare Disease Day

This year, Rare Diseases Day (RDD) falls on the rarest day of all in 2024 – 29 February! The event, held annually, aims to raise awareness of rare diseases and their impact on those living with them, their families, and caregivers.

At Janssen, we are committed to this goal, and are working to drive change for the 300 million people worldwide (and approximately 30 million in Europe) who are living with one of the 6,000-plus rare diseases. Our participation in awareness events, such as RDD, is an integral part of this.

We make strides by focused research and development programs to ultimately bring new, groundbreaking medicines to those affected by rare diseases. With our expertise in therapeutic areas like Pulmonary Hypertension, Retina, Immunology, Oncology and Neuroscience, we leverage scientific and operational knowledge to make a difference. Collaborating globally with partners and utilizing innovative tools, we are invested in improving health outcomes for individuals impacted by rare diseases.

At Janssen, we understand the importance of time for those affected by rare diseases. Patients shouldn't have to wait endlessly for diagnosis and treatment. That's why we focus on areas where we have the potential to make a substantial impact, including rare diseases. We tirelessly advance the science and chase breakthroughs in conditions like pulmonary arterial hypertension (PAH), AL amyloidosis, myasthenia gravis, rare inherited retinal diseases, rare maternal-fetal diseases, and rare blood disorders and cancers.

Our work at Janssen is fueled by the vision of a future where disease is a thing of the past. We are dedicated to finding lasting solutions and never cease in our pursuit.

Visit our dedicated pages

See examples of how we’re raising awareness for people living with rare disease.

Pulmonary Hypertension
Inherited retinal diseases

Rare diseases in numbers

 

 

* Image source of header and banner: Rare Disease Day website. https://www.rarediseaseday.org

References

ReSViNET. About RSV. Available from: http://www.resvinet.org/about-rsv.html. Last accessed: June 2021.
Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment Clin Microbiol Rev. 2016;30(1):277–319.
European foundation for the care of newborn infants. Respiratory syncytial virus (RSV). Available from: https://www.efcni.org/wp-content/uploads/2018/03/EFCNI_factsheet_RSV_web.pdf. Last accessed: June 2021.
Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005 Apr 28;352(17):1749-59.
ReSViNET. Symptoms. Available from: http://www.resvinet.org/symptoms.html. Last accessed: June 2021.
Centers for Disease Control and Prevention. RSV Prevention. Available from: https://www.cdc.gov/rsv/about/prevention.html. Last accessed: June2021.
World Health Organization. RSV vaccine research and development. Available from: https://www.who.int/immunization/research/development/ppc_rsv_vaccines/en/. Last accessed: June 2021.
Centers for Disease Control and Prevention. Symptoms and Care. Available from: https://www.cdc.gov/rsv/about/symptoms.html. Last accessed: June 2021.
Centres for Disease Control and Prevention. What you should know about flu antiviral drugs. Available from: https://www.cdc.gov/flu/treatment/whatyoushould.htm